Medical devices, healthcare technology and the business of care
510(k) clearance · K263005

Electric wheelchair (LW01301A02/LW01301A02L/LW01301A02T)

Anhui Longway Medical Technology Co., Ltd. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK263005

What did the FDA decide?

The FDA record for K263005 lists an Electric wheelchair under model designations LW01301A02, LW01301A02L and LW01301A02T, submitted by Anhui Longway Medical Technology Co., Ltd. The application is classified in Physical Medicine with product code ITI and is described in the source as a Traditional 510(k). The record does not state which components, software or design elements differ from any predicate device, so the specific changed item cannot be identified from the available data.

The recorded decision is SESE, dated 2026-10-28. For a 510(k), that decision means the submission was cleared to market; it is not a PMA approval. The source excerpt also carries a separate date of Nov 2, 2026, and the relationship between the two dates is not explained. No summary statement, indications for use, or predicate comparison is present, so clinical scope and any labeling claims remain unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Oct 28, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263005
Regulatory pathway
510(k) premarket notification
Product code
ITI
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wheelchair, Powered.

Product code
ITI
FDA device class
2

FDA decision timeline

  1. K263005 received

    Application receipt date recorded by FDA.

  2. K263005 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code ITI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Anhui Longway Medical Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mingguang

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records